Study of Serum C-reactive Protein as Prognostic Factor in Patients with Cerebrovascular Accidents

Document Type : Original Article

Authors

Department of General Medicine, Shyam Shah Medical College, Madhya Pradesh Medical Science University, Rewa, India

Abstract

Background and aim: Cerebrovascular accident may trigger the inflammatory response, increasing serum c-reactive protein (CRP) level. High CRP levels may be related to poor outcomes. We aimed to study the relationship between serum CRP levels in patients with cerebrovascular accidents and its outcome.
Material and methods: A total of 154 subjects of CVA were screened for the diagnostic and prognostic significance of serum CRP using Barthel index scoring and the National Institute of Health Stroke Scale on admission and the seventh day of admission.
Results: There was a significant rise in CRP levels in patients with stroke at the time of admission (p<0.001). More than 73% of total cases showed increased CRP levels at the time of admission. The National Institute of Health Stroke Scale (NIHSS) and Barthel index are good tools to assess the functional outcome of patients following a stroke with the rise in CRP levels.
Conclusions: Our study showed the short-term prognostic value of Serum c-reactive protein. The study showed that CRP concentration is an independent predictor of severity after cerebrovascular accidents. Thus, developing new neuroprotective therapies, if targeted to modulate cytokine-induced inflammation, could be a promising way to prevent early deterioration in acute stroke.

Keywords

Main Subjects

References

[1] Goldstein LB. Introduction for focused updates in cerebrovascular disease. Stroke. 2020;51(3):708-10. https://doi.org/10.1161/STROKEAHA.119.024159.
[2] Jauch EC, Saver JL, Adams Jr HP, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870-947. https://doi.org/10.1161/STR.0b013e318284056a.
[3] McColl BW, Allan SM, Rothwell NJ. Systemic inflammation and stroke: aetiology, pathology and targets for therapy. Biochemical Society Transactions. 2007;35(5):1163-5. https://doi.org/10.1042/BST0351163.
[4]  Den Hertog HM, Van Rossum JA, Van Der Worp HB, Van Gemert HM, de Jonge R,  Koudstaal PJ, et al. C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. Journal of neurology. 2009;256:2003-8. https://doi.org/10.1007/s00415-009-5228-x.
 [5] Di Napoli M, Elkind MS, Godoy DA, Singh P, Papa F, Popa-Wagner A. Role of C-reactive protein in cerebrovascular disease: a critical review. Expert review of cardiovascular therapy. 2011;9(12):1565-84. https://doi.org/10.1586/erc.11.159.
[6]  Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke. 2001;32(4):917-24. https://doi.org/10.1161/01.STR.32.4.917.
[7] Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001;32(11):2575-9. https://doi.org/10.1161/hs1101.098151.
[8] Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke. 1999;30(5):981-5. https://doi.org/10.1161/01.STR.30.5.981.
[9] Smith CJ, Emsley HC, Vail A, Georgiou RF, Rothwell NJ, Tyrrell PJ, et al. Variability of the systemic acute phase response after ischemic stroke. Journal of the neurological sciences. 2006;251(1-2):77-81. https://doi.org/10.1016/j.jns.2006.09.011.
[10] Gill R, Kemp JA, Sabin C, Pepys MB. Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats. Journal of Cerebral Blood Flow & Metabolism. 2004;24(11):1214-8. https://doi.org/ 10.1097/01.WCB.0000136517.61642.99.
[11] Montaner J, Fernandez-Cadenas I, Molina CA, Ribó M, Huertas R, Rosell A, et al. Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke. 2006;37(5):1205-10. https://doi.org/10.1161/01.STR.0000217744.89208.4e.
[12] Topakian R, Strasak AM, Nussbaumer K, Haring HP, Aichner FT. Prognostic value of admission C-reactive protein in stroke patients undergoing iv thrombolysis. Journal of neurology. 2008;255:1190-6. https://doi.org/10.1007/s00415-008-0866-y.
[13] Collin C, Wade DT, Davies S, Horne V. The Barthel ADL Index: a reliability study. International disability studies. 1988;10(2):61-3. https://doi.org/10.3109/09638288809164103.
[14] O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. The lancet. 2016;388(10046):761-75. https://doi.org/10.1016/S0140-6736(16)30506-2.
[15] Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke. 2002;33(10):2459-64. https://doi.org/10.1161/01.STR.0000029828.51413.82.
International Journal of Scientific Research in Dental and Medical Sciences
Volume 5, Issue 1
March 2023
Pages 7-15

Files

History

  • Receive Date: 19 January 2023
  • Revise Date: 02 March 2023
  • Accept Date: 09 March 2023

Share

How to cite

Statistics